Back
Speaker illustration

Mr Yvan Courageux

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

Member of:

Heart Failure Association

Yvan Courageux, Predoctoral Researcher, graduated with a degree in Molecular & Cellular Biology from the University of Rennes 1 in 2019. He is a native French speaker, fluent in both English and Spanish. Since 2021, his research has been focused on the production of GMP-grade Extracellular Vesicles as a novel therapeutic approach for the treatment of myocardial infarction. Furthermore, during his professional career in 2019, he contributed to the development and utilization of an iPSC-based model for Parkinson’s disease. He has served as the first author of one manuscript and as a co-author of two manuscripts. Among these, one includes a series of guidelines proposed by the ISEV consortium aimed at standardizing work in the field of extracellular vesicles. Overall, he possesses a deep understanding of the fundamentals of clinical translation and is qualified to undertake GMP translation of production protocols for clinical applications.

Presentations

HFWM: Large-scale manufacturing of GMP-grade Wharton's Jelly Mesenchymal Stromal Cell-derived Extracellular Vesicles: in vitro characterization and in vivo assessment for cardiac regeneration

Event: Heart Failure 2024

Topic: Gene Therapy, Cell Therapy

Session: ePosters in basic science 6

Access
Thumbnail

Large-scale manufacturing of GMP-grade Wharton's Jelly Mesenchymal Stromal Cell-derived Extracellular Vesicles: in vitro characterization and in vivo assessment for cardiac regeneration

Event: HFA Winter Research Meeting on Translational Heart Failure 2024

Topic: Microvesicles, Exosomes

Session: YIA Poster Session

Access
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources